1. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector Progress report 2009 Slide set – six summary data slides and all 40 figures from the report

2. Towards universal access: progress report 2009 | 21 February 2014 2 |2 | Increase in antiretroviral therapy in low- and middle-income countries, adults and children [combined], December 2007–December 2008 Geographical regionNumber of people receiving ARV therapy December 2008 Number of people receiving ARV therapy December 2007 Increase in one year Sub-Saharan Africa2 925 0002 100 00039% Latin America and the Caribbean445 000 390 00014% East, South and South-East Asia565 000420 00035% Europe and Central Asia85 000 54 00039% North Africa and the Middle East10 0007 00043% Total 4 030 000 [3.7–4.4 million] 2 970 000 [2.7–3.3 million] 36%

3. Towards universal access: progress report 2009 | 21 February 2014 3 |3 | Antiretroviral therapy coverage in low- and middle-income countries, adults and children [combined], December 2008 Geographical regionEstimated number of people receiving ARV therapy Estimated number of people needing ARV therapy Antiretroviral therapy coverage Sub-Saharan Africa2 925 0006 700 00044% Latin America and the Caribbean445 000 820 00054% East, South and South-East Asia565 0001 500 00037% Europe and Central Asia85 000 370 00023% North Africa and the Middle East10 00068 00014% Total 4 030 000 [3.7–4.4 million] 9 500 000 [8.6–10 million] 42% [40–47%]

4. Towards universal access: progress report 2009 | 21 February 2014 4 |4 | Antiretroviral therapy coverage in low- and middle-income countries, adults (15 years), December 2008 Geographical regionReported number of adults (15 years) receiving ARV therapy Estimated number of adults needing ARV therapy Antiretroviral therapy coverage Sub-Saharan Africa2 700 0006 100 00044% Latin America and the Caribbean429 000 800 00054% East, South and South-East Asia537 0001 500 00036% Europe and Central Asia80 000 370 00022% North Africa and the Middle East9 40062 00015% Total 3 755 000 8 800 000 [8.1–9.5 million] 43% [39–46%]

5. Towards universal access: progress report 2009 | 21 February 2014 5 |5 | Antiretroviral therapy coverage in low- and middle-income countries, children (0–14 years), December 2008 Geographical regionReported number of children (0–14 years) receiving ARV therapy Estimated number of children needing ARV therapy Antiretroviral therapy coverage Sub-Saharan Africa224 900640 00035% Latin America and the Caribbean16 100 21 00076% East, South and South-East Asia30 00058 00052% Europe and Central Asia4 200 4 90085% North Africa and the Middle East4006 7006% Total 275 700 730 000 [580 000–880 000] 38% [31–47%]

6. Towards universal access: progress report 2009 | 21 February 2014 6 |6 | Prevention of mother-to-child transmission coverage in low- and middle- income countries, December 2008 Geographical regionReported number of pregnant women living with HIV receiving ARVs for PMTCT Estimated number of pregnant women living with HIV needing ARVs for PMTCT Prevention of mother-to- child transmission coverage Sub-Saharan Africa576 8001 280 00045% Latin America and the Caribbean17 100 32 00054% East, South and South-East Asia21 70085 00025% Europe and Central Asia12 600 13 40094% North Africa and the Middle East<20013 4001% Total 628 400 1 400 000 [1.1–1.7 million] 45% [37–57%]

7. Towards universal access: progress report 2009 | 21 February 2014 7 |7 | Number of people receiving antiretroviral therapy in low- and middle-income countries, by region, 2002–2008

8. Towards universal access: progress report 2009 | 21 February 2014 8 |8 | Fig. 2.1. Transaction volumes of rapid HIV tests, 2004–2008

9. Towards universal access: progress report 2009 | 21 February 2014 9 |9 | Fig. 2.2. Reported number of health facilities providing HIV testing and counselling services in low- and middle-income countries with comparable data, by region, 2007 and 2008

10. Towards universal access: progress report 2009 | 21 February 2014 10 | Fig. 2.3. Percentage of women with HIV testing and counselling and percentage of women with secondary or higher education, district comprehensive assessment districts in Burkina Faso, Haiti and Zambia, 2008

11. Towards universal access: progress report 2009 | 21 February 2014 11 | Fig. 2.4. Percentage of women and men receiving an HIV test and test results in the 12 months preceding the survey in countries with repeat population surveys, 2003–2008

12. Towards universal access: progress report 2009 | 21 February 2014 12 | Fig. 2.5. Percentage of women and men ( 15 years) who had ever received an HIV test and test results, South Africa, 2002, 2005 and 2008

13. Towards universal access: progress report 2009 | 21 February 2014 13 | Fig. 3.1. Situation analysis of harm reduction interventions in the Middle East and North Africa at baseline, 2008

14. Towards universal access: progress report 2009 | 21 February 2014 14 | Fig. 3.2. Blood donation per 1000 population, 2007

15. Towards universal access: progress report 2009 | 21 February 2014 15 | Fig. 4.1. Number of people receiving antiretroviral therapy in low- and middle-income countries, by region, 2002–2008

16. Towards universal access: progress report 2009 | 21 February 2014 16 | Fig. 4.2. Measuring attrition from antiretroviral therapy programmes

17. Towards universal access: progress report 2009 | 21 February 2014 17 | Fig. 4.3. Retention on antiretroviral therapy at 12 months after initiation of treatment in 61 low- and middle-income countries by region, 2008

18. Towards universal access: progress report 2009 | 21 February 2014 18 | Fig. 4.4. 12-month retention of people receiving antiretroviral therapy in selected treatment sites, Papua New Guinea, 2008

19. Towards universal access: progress report 2009 | 21 February 2014 19 | Fig. 4.5. Trends in retention on antiretroviral therapy in low- and middle- income countries by region, 2008

20. Towards universal access: progress report 2009 | 21 February 2014 20 | Fig. 4.6. Trends over time in the median CD4 count at baseline count of 36 715 adults starting antiretroviral therapy between 2001 and 2006

21. Towards universal access: progress report 2009 | 21 February 2014 21 | Fig. 4.7. Antiretroviral therapy coverage and all-cause mortality in South Africa, 2003–2006

22. Towards universal access: progress report 2009 | 21 February 2014 22 | Fig. 4.8. Countries implementing at least one element of the WHO Global Strategy for the Prevention and Assessment of HIV Drug Resistance and locations of HIV drug resistance testing laboratories, February 2009

23. Towards universal access: progress report 2009 | 21 February 2014 23 | Fig. 4.9. Main first-line antiretroviral regimens used among 2.4 million adults in 36 low- and middle-income countries, December 2008

24. Towards universal access: progress report 2009 | 21 February 2014 24 | Fig. 4.10. Main second-line antiretroviral regimens used among adults (n=51 135) in 36 low- and middle-income countries, December 2008

25. Towards universal access: progress report 2009 | 21 February 2014 25 | Fig. 4.11. First-line regimens used among children (n=177 064) in 36 low- and middle-income countries, December 2008

26. Towards universal access: progress report 2009 | 21 February 2014 26 | Fig. 4.12. Second-line regimens used among children (n=5997) in 35 low- and middle-income countries, December 2008

27. Towards universal access: progress report 2009 | 21 February 2014 27 | Fig. 4.13. Median annual cost (in US dollars) of first-line antiretroviral drug regimens in low-income countries by year, 2004–2008

28. Towards universal access: progress report 2009 | 21 February 2014 28 | Fig. 4.14. Median annual cost (in US dollars) of first-line antiretroviral drug regimens in lower-middle-income countries by year, 2004–2008

29. Towards universal access: progress report 2009 | 21 February 2014 29 | Fig. 4.15. Median price (in US dollars) of first-line antiretroviral drug regimens in upper-middle-income countries by year, 2004–2008

30. Towards universal access: progress report 2009 | 21 February 2014 30 | Fig. 4.16. Estimated HIV prevalence (%) among people newly infected with TB, 2007

31. Towards universal access: progress report 2009 | 21 February 2014 31 | Fig. 4.17. Rates of HIV testing among people with TB in countries in sub- Saharan Africa, 2004–2007

32. Towards universal access: progress report 2009 | 21 February 2014 32 | Fig. 5.1. Number of low- and middle-income countries with national scale- up plans including population-based targets for preventing mother-to-child transmission and for HIV care and treatment for children, by region, 2008

33. Towards universal access: progress report 2009 | 21 February 2014 33 | Fig. 5.2. Percentage of women and men aged 15–49 years with comprehensive knowledge a of HIV in countries with recent population- based surveys (2007–2008)

34. Towards universal access: progress report 2009 | 21 February 2014 34 | Fig. 5.3. Reported percentage condom use at last sexual intercourse among women 15–49 years old who had sex in the past year by five-year age groups in selected population-based surveys, 2005–2007

35. Towards universal access: progress report 2009 | 21 February 2014 35 | Fig. 5.4. Unmet need for family planning among married women 15–49 years old (%) in countries with a generalized epidemic, 2006–2008

36. Towards universal access: progress report 2009 | 21 February 2014 36 | Fig. 5.5. Percentage of pregnant women who received an HIV test in low- and middle-income countries by region, 2004–2008 a

37. Towards universal access: progress report 2009 | 21 February 2014 37 | Fig. 5.6. Percentage of pregnant women who received an HIV test in Malawi, 2004–2008

38. Towards universal access: progress report 2009 | 21 February 2014 38 | Fig. 5.7. Percentage of pregnant women with HIV receiving antiretrovirals for preventing mother-to-child transmission of HIV in low- and middle- income countries by region, 2004–2008

39. Towards universal access: progress report 2009 | 21 February 2014 39 | Fig. 5.8. Percentage of pregnant women living with HIV who received antiretrovirals to prevent mother-to-child transmission of HIV in Côte dIvoire, 2005–2008

40. Towards universal access: progress report 2009 | 21 February 2014 40 | Fig. 5.9. Percentage of pregnant women living with HIV receiving antiretrovirals to prevent the mother-to-child transmission of HIV in 20 countries with the highest HIV disease burden among pregnant women (in descending order), 2008

41. Towards universal access: progress report 2009 | 21 February 2014 41 | Fig. 5.10. Coverage of antiretrovirals to prevent the mother-to-child transmission of HIV, 2008

42. Towards universal access: progress report 2009 | 21 February 2014 42 | Fig. 5.11. Percentage distribution of various antiretroviral regimens provided to pregnant women in low- and medium-income countries in 2007 and 2008, based on available data

43. Towards universal access: progress report 2009 | 21 February 2014 43 | Fig. 5.12. Contribution of the 20 countries with the largest numbers of women needing antiretrovirals for preventing the mother-to-child transmission of HIV to the global gap to reach 80% of those in need, 2008

44. Towards universal access: progress report 2009 | 21 February 2014 44 | Fig. 5.13. Coverage of antiretroviral prophylaxis among infants born to mothers living with HIV in low- and middle-income countries by region, 2008

45. Towards universal access: progress report 2009 | 21 February 2014 45 | Fig. 5.14. Percentage of pregnant women living with HIV and infants born to them who received antiretrovirals for preventing mother-to-child transmission, 2004–2008

46. Towards universal access: progress report 2009 | 21 February 2014 46 | Fig. 5.15. Average age of infants at their first HIV DNA test in Namibia in weeks, 2006–2008

47. Towards universal access: progress report 2009 | 21 February 2014 47 | Fig. 5.16. Percentage of children receiving antiretroviral therapy in low- and middle-income countries, 2005–2008